braeburnpharmaceuticals.com
Braeburn Pharmaceuticals to Initiate New Clinical Study for Probuphine Following Clear Guidance from FDA - Braeburn Pharmaceuticals
https://braeburnpharmaceuticals.com/braeburn-pharmaceuticals-to-initiate-new-clinical-study-for-probuphine-following-clear-guidance-from-fda
R & D. R & D. Braeburn Pharmaceuticals to Initiate New Clinical Study for Probuphine Following Clear Guidance from FDA. April 30, 2014. January 20, 2017. Study of approximately 180 opioid dependent patients expected to begin enrollment by mid-year 2014. Princeton, NJ April 30, 2014 Braeburn Pharmaceuticals announced today the initiation of a new clinical trial for Probuphine. The efficacy and safety of Probuphine has been studied in several clinical trials, including a 163-patient, placebo-controlled stu...
braeburnpharmaceuticals.com
Braeburn Pharmaceuticals' Probuphine® Study Hits Enrollment Milestone - Braeburn Pharmaceuticals
https://braeburnpharmaceuticals.com/braeburn-pharmaceuticals-probuphine-study-hits-enrollment-milestone
R & D. R & D. Braeburn Pharmaceuticals’ Probuphine Study Hits Enrollment Milestone. September 25, 2014. January 20, 2017. Braeburn Pharmaceuticals’ Probuphine. Study Hits Enrollment Milestone. 95 of 180 Patients Enrolled; Additional Patients Screened, Awaiting Randomization. Princeton, N.J. Sept. 24, 2014 Braeburn Pharmaceuticals today announced that it has surpassed the midway point for patient enrollment in its Phase 3 study of Probuphine. The efficacy and safety of Probuphine has been studied in sever...
braeburnpharmaceuticals.com
Braeburn Pharmaceuticals Enrolls First Patients In Late-Stage Clinical Study Of Probuphine® For Opioid Dependence - Braeburn Pharmaceuticals
https://braeburnpharmaceuticals.com/braeburn-pharmaceuticals-enrolls-first-patients-in-late-stage-clinical-study-of-probuphine-for-opioid-dependence
R & D. R & D. Braeburn Pharmaceuticals Enrolls First Patients In Late-Stage Clinical Study Of Probuphine For Opioid Dependence. July 21, 2014. January 20, 2017. Braeburn Pharmaceuticals Enrolls First Patients In Late-Stage Clinical Study Of Probuphine. Princeton, NJ July 21, 2014 Braeburn Pharmaceuticals today announced that the first patients have been enrolled in its Phase 3 clinical study of Probuphine. Is an investigational subdermal implant designed to deliver continuous, around the clock blood leve...